Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943380 · ClinicalTrials.gov registry record
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
A clinical trial, sponsored by Pacific Edge Limited.
- Completed
- Registry status
- 682
- Enrollment target
NCT04943380: Completed study, sponsored by Pacific Edge Limited.
NCT04943380 is a clinical trial that has completed, run by Pacific Edge Limited. The registered enrollment target is 682 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04943380 has completed, sponsored by Pacific Edge Limited.
- COMPLETED
- Registry status
- 682 participants
- Enrollment target
Study Summary
Prospective observational study to validate the performance characteristics and clinical utility of Cxbladder tests in a Veterans Affairs cohort.
Primary Outcome
The Cxbladder test results will be compared to that of cystoscopy, which is the gold standard method for diagnosing urothelial cancer; the true positive and true negative rates will be measured, along with the false positive and false negative rates of the test. The results will be reported as sensitivity and specificity of the Cxbladder test for detecting urothelial cancer in patients with hematuria
Interventions
- DIAGNOSTIC_TEST Cxbladder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 682 participants |
| Start Date | 2019-11-08 |
| Est. Completion | 2024-01-18 |
What the finished NCT04943380 record still lists
NCT04943380 is an observational study that tracks outcomes without assigning an intervention. The registered 682 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cxbladder is the first listed.
NCT04943380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04943380 about?
NCT04943380 is a clinical study titled "Efficacy and Utility of Cxbladder Tests in Hematuria Patients". Prospective observational study to validate the performance characteristics and clinical utility of Cxbladder tests in a Veterans Affairs cohort.
What is the current status of trial NCT04943380?
This trial is currently completed. The enrollment target is 682 participants. The study started on 2019-11-08. Estimated completion is 2024-01-18.
What interventions are being tested in trial NCT04943380?
The interventions under investigation include: Cxbladder (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04943380?
This trial is sponsored by Pacific Edge Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI